Rigel Pharmaceuticals (RIGL) FCF Margin Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Rigel Pharmaceuticals | 551.62 Mn | 404.94 Mn | 54.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,935.00 |
| Dec 31, 2025 | 11,864.00 |
| Sep 30, 2025 | 14,160.00 |
| Jun 30, 2025 | 11,738.00 |
| Mar 31, 2025 | 496.00 |
| Dec 31, 2024 | 9,176.00 |
| Sep 30, 2024 | 11,108.00 |
| Jun 30, 2024 | 16,192.00 |
| Mar 31, 2024 | -948.00 |
| Dec 31, 2023 | -4,801.00 |
| Sep 30, 2023 | 41,116.00 |
| Jun 30, 2023 | 157,091.00 |
| Dec 31, 2022 | -48,372.00 |
| Sep 30, 2022 | 190,269.00 |
| Mar 31, 2022 | 42,591.00 |
| Dec 31, 2021 | 32,225.00 |
| Sep 30, 2021 | 55,841.00 |
| Jun 30, 2021 | 42,579.00 |
| Mar 31, 2021 | 42,748.00 |
| Dec 31, 2020 | 7,605.00 |
| Sep 30, 2020 | -3,187.00 |
| Jun 30, 2020 | 26,410.00 |
| Mar 31, 2020 | -83,102.00 |
| Dec 31, 2018 | 36,223.00 |
| Jun 30, 2018 | -814.00 |
| Mar 31, 2017 | 273,249.00 |
| Sep 30, 2016 | -30,036.00 |
| Jun 30, 2016 | 430,491.00 |
| Sep 30, 2015 | -4,759.00 |